Lansforsakringar Fondforvaltning Ab (Publ) Royalty Pharma PLC Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $8.19 Billion
- Q4 2024
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 150,344 shares of RPRX stock, worth $5.07 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
150,344Holding current value
$5.07 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
434Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.33 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$776 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$572 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$476 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...